Paresh Chaudhari
About Paresh Chaudhari
Paresh Chaudhari is the Promotional Review Champion and Associate Director of US HEOR at Bristol-Myers Squibb in Lawrenceville, New Jersey. He has extensive experience in health economics and outcomes research across multiple pharmaceutical companies.
Current Position at Bristol-Myers Squibb
Paresh Chaudhari currently serves as the Promotional Review Champion and Associate Director, US HEOR at Bristol-Myers Squibb in Lawrenceville, New Jersey, United States. In this capacity, he is responsible for overseeing promotional review activities and contributing to health economics and outcomes research (HEOR) initiatives. His role necessitates a thorough understanding of both promotional strategies and HEOR methodologies.
Previous Experience at Otsuka Pharmaceutical Companies
From 2016 to 2017, Paresh Chaudhari worked at Otsuka Pharmaceutical Companies in Princeton, New Jersey, as an Associate Director. During his one-year tenure, he took on responsibilities that further deepened his expertise in the pharmaceutical industry, particularly in areas related to HEOR.
Tenure at Takeda Pharmaceuticals
Paresh Chaudhari held the position of Senior Manager in Global Outcomes and Epidemiology Research at Takeda Pharmaceuticals from 2014 to 2016, in Deerfield, Illinois. Over a period of two years, he focused on global outcomes research, bringing valuable insights into epidemiology and health economics, which contributed to the larger goals of the company.
Senior Management Role at Astellas Pharma
Between 2011 and 2014, Paresh Chaudhari worked as a Senior Manager in HEOR at Astellas Pharma in Deerfield, Illinois. His role evolved from a Manager position in HEOR from 2009 to 2011, where he managed health economics and outcomes research projects aimed at supporting the company’s pharmaceutical solutions.
Academic Background in Public Health and Pharmacy
Paresh Chaudhari holds a Master of Public Health (MPH) from Emory University's Rollins School of Public Health, completed between 2003 and 2006. He also earned a Bachelor of Science from Rutgers' Ernest Mario School of Pharmacy, which he attended from 1996 to 2001. His academic qualifications laid a robust foundation for his extensive career in health economics and outcomes research (HEOR).